Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE2
GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
- Status
- COMPLETED
- Phase
- PHASE2
Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
- Status
- COMPLETED
- Phase
- PHASE3
Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Empowering Immigrants in the Greater Boston Area to Connect to HBV Care
- Status
- UNKNOWN
- Phase
- N/A
Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients
- Status
- COMPLETED
- Phase
- N/A
HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection
- Status
- COMPLETED
- Phase
- PHASE2
Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning
- Status
- COMPLETED
- Phase
- PHASE4